1Nishioka Y, Hitao M, Robbins PD, et al. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res, 1999,59:4035-4041.
2Aoki H, Mizuno M, Natsume A, et al. Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cyctotoxic T lymphocytes in mouse brain tumor. Cancer Immunol Immunother,2001,50:463-468.
3Nishimura N, Nishioka Y, Shinohara T, et al. Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells. Hum Gene Ther, 2001,12:333-346.
4Yamanaka R, Zullo SA, Ramsey J, et al. Marked enhancement of antitumor immune in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interlekin-12. J Neurosurg, 2002,97:611-618.
5Yamanacement R, Zullo SA, Tanaka R, et al. Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus-mediated complementary DNA. J Neurosurg, 2001,94: 474-481.
6Miller G, Lahrs S, Pillarisetty VG, et al. Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cellmediared tumor protection. Cancer Res,2002,62:5260-5266.
7Liau LM, Black KL, Prins RM, et al. Treatment of intracranial gliomas with bone marrow-derived dendritic cell pulsed with tumor antigens. J Neurosurg,1999,90:1115-1124.
8Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines. Stem Cells, 1997,15: 94-103.
9Ni HT, Spellman SR, Jean WC, et al. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas. J Neurooncol,2001,51:1-9.
10Okada J, Tahara H, Shurin MR, et al. Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunty against intracranial neoplasms. Int J Cancer, 1998,78: 196-201.
